Omnicomm Systems Inc (OMCM) 0.1900 $OMCM
OmniComm Systems Announces Innovative New Release of TrialMaster(R) EDC
Marketwired - Wed Apr 01, 7:00AM CDT
OmniComm Systems, Inc. (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, announces the general availability of release 4.2.1 of TrialMaster, its flagship product for Electronic Data Capture (EDC). This release provides new capabilities to capture audit trail information for electronic source data, dramatic productivity enhancements in the automated generation of SDTM datasets, the ability for sites in registry studies to export their own data, and over 100 other targeted enhancements. This release also contains performance improvements that allow TrialMaster to effortlessly support the industry's biggest studies.
Improving ECG Data Quality and Availability: Automatic Transmission of Data From Devices Into eSource Systems, New Webinar Hosted by Xtalks
Marketwired - Wed Mar 25, 6:05AM CDT
Join presenters Mark Mentzer, Vice President of Strategic Partnerships at Mortara Instrument, and Michelle King, Director of Early Phase Consulting at OmniComm Systems, Inc. for a complementary webinar and learn how OmniComm and Mortara use the bi-directional communication between Mortara ECG devices and the TrialOne® eSource system to automatically transmit information between the two, and how the implementation of direct data capture is able to improve clinical trial data quality and availability. There will be two live broadcasts on Tuesday, April 21, 2015, at 9am EDT (2pm BST /GMT +1), and 11am EDT.
E-Clinical Trial Technologies - Global Strategic Business Report 2015-2020: Electronic Patient Record (ePRO) Solutions Fast Replacing Paper-Based PRO Systems
M2 - Wed Mar 25, 5:15AM CDT
Research and Markets (http://www.researchandmarkets.com/research/d4nrg7/eclinical_trial) has announced the addition of the "E-Clinical Trial Technologies - Global Strategic Business Report" report to their offering. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a three-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for E-Clinical Trial Technologies in US$ Million by the following Segments: - Electronic Data Capture (EDC) Solutions - Clinical Trial Management System (CTMS) - Electronic Patient Reported Outcome (ePRO) - Randomization and Trial Supply Management (RTSM) The report profiles 85 companies including many key and niche players such as: - Almac Group (UK) - ArisGlobal LLC (US) - BioClinica (US) - Clinipace Worldwide (US) - Cmed Technology Ltd (UK) - DATATRAK International, Inc. (US) - DSG Inc. (US) - DZS Software Solutions, Inc. (US) - eClinForce, Inc (US) - eClinical Insights, Inc. (US) - eResearch Technology, Inc. (US) - Integrated Clinical Solutions, Inc. (US) - Medidata Solutions, Inc. (US) - MedNet Solutions (US) - Merge Healthcare, Inc. (US) - Nextrials Inc. (US) - OmniComm Systems, Inc. (US) - Oracle Health Sciences (US) - PAREXEL International Corp. (US) - Perceptive Informatics, Inc. (US) - PHT Corp. (US) - Prelude Dynamics LLC (US) - SAS Institute Inc. (US) - Target Health Inc. (US) - Trianz Solutions (US) Key Topics Covered: 1. INDUSTRY OVERVIEW 2. MARKET DYNAMICS 3. COMPETITIVE LANDSCAPE 4. PRODUCT PROFILE 5. PRODUCT/SERVICE INTRODUCTIONS 6. RECENT INDUSTRY ACTIVITY 7. FOCUS ON SELECT PLAYERS 8. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 85 (including Divisions/Subsidiaries - 92) - The United States (58) - Canada (2) - Japan (1) - Europe (27) - - France (2) - - Germany (3) - - The United Kingdom (12) - - Italy (2) - - Rest of Europe (
- Asia-Pacific (Excluding Japan) (4) For more information visit http://www.researchandmarkets.com/research/d4...ical_trial
PRXL: 66.93 (+0.45), MDSO: 54.28 (+1.12), MRGE: 4.58 (+0.03)
Veloxis Pharmaceuticals Chooses TrialMaster(R) EDC for Risk-Based Monitoring
Marketwired - Wed Mar 11, 7:00AM CDT
OmniComm Systems, Inc. (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, today announced that after a rigorous evaluation process of various commercially available EDC technologies, Veloxis selected TrialMaster EDC to run its Phase IV clinical studies.
OmniComm Systems(R) TrialOne(R) Suite Selected by ICON for Phase I Clinic Automation
Marketwired - Tue Mar 03, 7:01AM CST
OmniComm Systems, Inc. (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, today announced the signing of a multi-year agreement with ICON for OmniComm Systems' market leading TrialOne technology for Phase I clinic automation. ICON is one of the world's largest contract research organizations (CROs) with around 10,600 employees in 38 countries. ICON provides drug development solutions and services on a global basis to the pharmaceutical, biotechnology, and medical device industries supporting all stages of the clinical development process.
OmniComm Systems Appoints General Manager of China; Mr. Feng Cheng Focuses on Expanding Growth and Business Operations
Marketwired - Mon Feb 09, 7:01AM CST
OmniComm Systems, Inc. (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, announces the appointment of Mr. Feng Cheng as general manager of OmniComm, China. Mr. Cheng will lead OmniComm's long-term regional strategy, identifying and developing business expansion and growth initiatives.
OmniComm Systems buys interactive response technology assets from ClinQuest for undisclosed amount
M2 - Mon Feb 09, 5:34AM CST
OmniComm Systems (OTCQB:OMCM), a provider of software solutions provider to the life sciences industry, revealed on Friday that it has completed the acquisition of the interactive response technology (IRT) assets from ClinQuest, a healthcare product development service provider.
OmniComm Systems(R) Announces 141% YOY Growth in Total Contract Value
Marketwired - Fri Jan 16, 7:00AM CST
OmniComm Systems, Inc., (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, announces record growth in total contract value for 2014. Total contract value grew over 141% from 2013. A significant portion, 33%, of total contract value, came from companies that are within the 10 largest global contract research organizations (CRO) and pharmaceutical companies. The company experienced healthy year-over-year contract value growth from new and existing clients, 388% and 51% respectively.
Streamline Health Solutions (STRM) in Focus: Stock Up 13% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Dec 31, 8:46AM CST
Streamline Health Solutions (STRM) was a big mover last session, with shares rising almost 13% on the day.
STRM: 2.32 (-0.07)
OmniComm Systems(R) Recognizes Excellence in Clinical Research and Development at Innovation Forum 2014
Marketwired - Fri Dec 19, 7:00AM CST
OmniComm Systems, Inc., (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, recognizes excellence in innovation at OmniComm's 4th annual Innovation Forum customer summit.
Allscripts Healthcare (MDRX) Grows on Higher EHR Adoption - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 10, 2:50PM CST
We note that Allscripts Healthcare Solutions Inc. (MDRX) continues to benefit from the HITECH Act, as reflected by the significant number of client admissions during the year and additional related orders for its EHR products.
MDRX: 14.07 (+0.09), MRGE: 4.58 (+0.03), CERN: 67.77 (+0.43)
Merge Healthcare (MRGE) Worth Watching: Stock Gains 6.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 04, 8:46AM CST
Merge Healthcare (MRGE) was a big mover last session, with shares rising roughly 7% on the day.
ANIP: 52.86 (+0.74), MRGE: 4.58 (+0.03), AFFX: 12.48 (+0.01)
OmniComm Systems reports rise of 135% YOY in contract value through Q3 2014
M2 - Thu Nov 27, 6:32AM CST
Medical clinical data company OmniComm Systems (OTCQB:OMCM) stated on Wednesday that its total contract value rose over 260% in Q3 2014 over the same period in 2013.
OmniComm Systems(R) Announces 135% YOY Growth in Total Contract Value Through Q3 2014
Marketwired - Wed Nov 26, 7:00AM CST
OmniComm Systems, Inc., (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, today announced that Q3 2014 total contract value was up by over 260% from the same period in 2013. Year-over-year total contract value grew over 135%. New clients accounted for over 73% of all new contracts through Q3 2014 and 20% of all contracts had a term life in excess of 30 months. The record contract growth is attributed to premier client wins and the success of TrialMaster(R) EDC technology, TrialOne(R) Phase I clinic automation and Promasys(R) medical research data management solutions.
Larix, Denmark's Full Service Contract Research Organization, Selects OmniComm's(R) TrialMaster(R) Electronic Data Capture Solution
Marketwired - Thu Nov 20, 7:01AM CST
OmniComm Systems, Inc., (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, is pleased to announce that Larix; a full service Danish contract research organization (CRO) offering statistics, data management and medical writing, has selected TrialMaster electronic data capture (EDC) as its standard EDC technology. Located in the heart of the Denmark's Medicon Valley, one of Europe's preeminent centers for the life science industry, Larix's clinical development services are utilized by an ever increasing number of domestic and international organizations.
Belgian Contract Research Organization, Business & Decision Life Sciences, Partners With OmniComm Systems(R)
Marketwired - Tue Oct 28, 7:04AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM), a leading global provider of data management solutions for clinical trials, today announced a partnership with Business & Decision Life Sciences (BDLS), a contract research organization (CRO) and life sciences information technology consultancy headquartered in Brussels, Belgium. This partnership enhances OmniComm's presence in key geographies as it continues to experience continued and sustained demand from within the European clinical market space for its electronic data capture (EDC) and clinical data management (CDM) cloud based technology. BDLS selected OmniComm's CRO Preferred Program to provide sponsors with access to the most innovative EDC technology and enhance its CRO and IT service offerings. BDLS plans to deploy TrialMaster EDC across a number of European trials over the next two years.
Top 10 Pharmaceutical Company Moves to OmniComm Systems'
R) OmniCloud(R)
Marketwired - Mon Oct 20, 7:01AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM), a global leading provider of clinical data management technology, was selected by a top 10 pharmaceutical company to migrate its on-premise clinical data management technology to OmniCloud (OmniComm's clinical cloud technology platform). This is part of an overarching corporate initiative to migrate all clinical development enterprise applications to the cloud. This is the largest initiative of its kind for OmniComm since the launch of OmniCloud in June of this year.
Leading In Vitro Diagnostics Company Selects OmniComm's(R) TrialMaster(R) Electronic Data Capture Solution
Marketwire - Wed Sep 17, 7:35AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM), a global leading provider of clinical data management technology, is pleased to announce that a leading in vitro diagnostics (IVD) company has selected TrialMaster electronic data capture (EDC) to support its clinical evaluation of innovative IVD products for rapid identification and antibiotic susceptibility testing of infectious pathogens.
OmniComm Systems Announces Innovative New Release of TrialMaster(R) EDC
Marketwired - Wed Apr 01, 7:00AM CDT
OmniComm Systems, Inc. (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, announces the general availability of release 4.2.1 of TrialMaster, its flagship product for Electronic Data Capture (EDC). This release provides new capabilities to capture audit trail information for electronic source data, dramatic productivity enhancements in the automated generation of SDTM datasets, the ability for sites in registry studies to export their own data, and over 100 other targeted enhancements. This release also contains performance improvements that allow TrialMaster to effortlessly support the industry's biggest studies.
Improving ECG Data Quality and Availability: Automatic Transmission of Data From Devices Into eSource Systems, New Webinar Hosted by Xtalks
Marketwired - Wed Mar 25, 6:05AM CDT
Join presenters Mark Mentzer, Vice President of Strategic Partnerships at Mortara Instrument, and Michelle King, Director of Early Phase Consulting at OmniComm Systems, Inc. for a complementary webinar and learn how OmniComm and Mortara use the bi-directional communication between Mortara ECG devices and the TrialOne® eSource system to automatically transmit information between the two, and how the implementation of direct data capture is able to improve clinical trial data quality and availability. There will be two live broadcasts on Tuesday, April 21, 2015, at 9am EDT (2pm BST /GMT +1), and 11am EDT.
E-Clinical Trial Technologies - Global Strategic Business Report 2015-2020: Electronic Patient Record (ePRO) Solutions Fast Replacing Paper-Based PRO Systems
M2 - Wed Mar 25, 5:15AM CDT
Research and Markets (http://www.researchandmarkets.com/research/d4nrg7/eclinical_trial) has announced the addition of the "E-Clinical Trial Technologies - Global Strategic Business Report" report to their offering. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a three-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for E-Clinical Trial Technologies in US$ Million by the following Segments: - Electronic Data Capture (EDC) Solutions - Clinical Trial Management System (CTMS) - Electronic Patient Reported Outcome (ePRO) - Randomization and Trial Supply Management (RTSM) The report profiles 85 companies including many key and niche players such as: - Almac Group (UK) - ArisGlobal LLC (US) - BioClinica (US) - Clinipace Worldwide (US) - Cmed Technology Ltd (UK) - DATATRAK International, Inc. (US) - DSG Inc. (US) - DZS Software Solutions, Inc. (US) - eClinForce, Inc (US) - eClinical Insights, Inc. (US) - eResearch Technology, Inc. (US) - Integrated Clinical Solutions, Inc. (US) - Medidata Solutions, Inc. (US) - MedNet Solutions (US) - Merge Healthcare, Inc. (US) - Nextrials Inc. (US) - OmniComm Systems, Inc. (US) - Oracle Health Sciences (US) - PAREXEL International Corp. (US) - Perceptive Informatics, Inc. (US) - PHT Corp. (US) - Prelude Dynamics LLC (US) - SAS Institute Inc. (US) - Target Health Inc. (US) - Trianz Solutions (US) Key Topics Covered: 1. INDUSTRY OVERVIEW 2. MARKET DYNAMICS 3. COMPETITIVE LANDSCAPE 4. PRODUCT PROFILE 5. PRODUCT/SERVICE INTRODUCTIONS 6. RECENT INDUSTRY ACTIVITY 7. FOCUS ON SELECT PLAYERS 8. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 85 (including Divisions/Subsidiaries - 92) - The United States (58) - Canada (2) - Japan (1) - Europe (27) - - France (2) - - Germany (3) - - The United Kingdom (12) - - Italy (2) - - Rest of Europe (
- Asia-Pacific (Excluding Japan) (4) For more information visit http://www.researchandmarkets.com/research/d4...ical_trial PRXL: 66.93 (+0.45), MDSO: 54.28 (+1.12), MRGE: 4.58 (+0.03)
Veloxis Pharmaceuticals Chooses TrialMaster(R) EDC for Risk-Based Monitoring
Marketwired - Wed Mar 11, 7:00AM CDT
OmniComm Systems, Inc. (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, today announced that after a rigorous evaluation process of various commercially available EDC technologies, Veloxis selected TrialMaster EDC to run its Phase IV clinical studies.
OmniComm Systems(R) TrialOne(R) Suite Selected by ICON for Phase I Clinic Automation
Marketwired - Tue Mar 03, 7:01AM CST
OmniComm Systems, Inc. (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, today announced the signing of a multi-year agreement with ICON for OmniComm Systems' market leading TrialOne technology for Phase I clinic automation. ICON is one of the world's largest contract research organizations (CROs) with around 10,600 employees in 38 countries. ICON provides drug development solutions and services on a global basis to the pharmaceutical, biotechnology, and medical device industries supporting all stages of the clinical development process.
OmniComm Systems Appoints General Manager of China; Mr. Feng Cheng Focuses on Expanding Growth and Business Operations
Marketwired - Mon Feb 09, 7:01AM CST
OmniComm Systems, Inc. (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, announces the appointment of Mr. Feng Cheng as general manager of OmniComm, China. Mr. Cheng will lead OmniComm's long-term regional strategy, identifying and developing business expansion and growth initiatives.
OmniComm Systems buys interactive response technology assets from ClinQuest for undisclosed amount
M2 - Mon Feb 09, 5:34AM CST
OmniComm Systems (OTCQB:OMCM), a provider of software solutions provider to the life sciences industry, revealed on Friday that it has completed the acquisition of the interactive response technology (IRT) assets from ClinQuest, a healthcare product development service provider.
OmniComm Systems(R) Announces 141% YOY Growth in Total Contract Value
Marketwired - Fri Jan 16, 7:00AM CST
OmniComm Systems, Inc., (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, announces record growth in total contract value for 2014. Total contract value grew over 141% from 2013. A significant portion, 33%, of total contract value, came from companies that are within the 10 largest global contract research organizations (CRO) and pharmaceutical companies. The company experienced healthy year-over-year contract value growth from new and existing clients, 388% and 51% respectively.
Streamline Health Solutions (STRM) in Focus: Stock Up 13% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Dec 31, 8:46AM CST
Streamline Health Solutions (STRM) was a big mover last session, with shares rising almost 13% on the day.
STRM: 2.32 (-0.07)
OmniComm Systems(R) Recognizes Excellence in Clinical Research and Development at Innovation Forum 2014
Marketwired - Fri Dec 19, 7:00AM CST
OmniComm Systems, Inc., (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, recognizes excellence in innovation at OmniComm's 4th annual Innovation Forum customer summit.
Allscripts Healthcare (MDRX) Grows on Higher EHR Adoption - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 10, 2:50PM CST
We note that Allscripts Healthcare Solutions Inc. (MDRX) continues to benefit from the HITECH Act, as reflected by the significant number of client admissions during the year and additional related orders for its EHR products.
MDRX: 14.07 (+0.09), MRGE: 4.58 (+0.03), CERN: 67.77 (+0.43)
Merge Healthcare (MRGE) Worth Watching: Stock Gains 6.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 04, 8:46AM CST
Merge Healthcare (MRGE) was a big mover last session, with shares rising roughly 7% on the day.
ANIP: 52.86 (+0.74), MRGE: 4.58 (+0.03), AFFX: 12.48 (+0.01)
OmniComm Systems reports rise of 135% YOY in contract value through Q3 2014
M2 - Thu Nov 27, 6:32AM CST
Medical clinical data company OmniComm Systems (OTCQB:OMCM) stated on Wednesday that its total contract value rose over 260% in Q3 2014 over the same period in 2013.
OmniComm Systems(R) Announces 135% YOY Growth in Total Contract Value Through Q3 2014
Marketwired - Wed Nov 26, 7:00AM CST
OmniComm Systems, Inc., (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, today announced that Q3 2014 total contract value was up by over 260% from the same period in 2013. Year-over-year total contract value grew over 135%. New clients accounted for over 73% of all new contracts through Q3 2014 and 20% of all contracts had a term life in excess of 30 months. The record contract growth is attributed to premier client wins and the success of TrialMaster(R) EDC technology, TrialOne(R) Phase I clinic automation and Promasys(R) medical research data management solutions.
Larix, Denmark's Full Service Contract Research Organization, Selects OmniComm's(R) TrialMaster(R) Electronic Data Capture Solution
Marketwired - Thu Nov 20, 7:01AM CST
OmniComm Systems, Inc., (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, is pleased to announce that Larix; a full service Danish contract research organization (CRO) offering statistics, data management and medical writing, has selected TrialMaster electronic data capture (EDC) as its standard EDC technology. Located in the heart of the Denmark's Medicon Valley, one of Europe's preeminent centers for the life science industry, Larix's clinical development services are utilized by an ever increasing number of domestic and international organizations.
Belgian Contract Research Organization, Business & Decision Life Sciences, Partners With OmniComm Systems(R)
Marketwired - Tue Oct 28, 7:04AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM), a leading global provider of data management solutions for clinical trials, today announced a partnership with Business & Decision Life Sciences (BDLS), a contract research organization (CRO) and life sciences information technology consultancy headquartered in Brussels, Belgium. This partnership enhances OmniComm's presence in key geographies as it continues to experience continued and sustained demand from within the European clinical market space for its electronic data capture (EDC) and clinical data management (CDM) cloud based technology. BDLS selected OmniComm's CRO Preferred Program to provide sponsors with access to the most innovative EDC technology and enhance its CRO and IT service offerings. BDLS plans to deploy TrialMaster EDC across a number of European trials over the next two years.
Top 10 Pharmaceutical Company Moves to OmniComm Systems'
R) OmniCloud(R) Marketwired - Mon Oct 20, 7:01AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM), a global leading provider of clinical data management technology, was selected by a top 10 pharmaceutical company to migrate its on-premise clinical data management technology to OmniCloud (OmniComm's clinical cloud technology platform). This is part of an overarching corporate initiative to migrate all clinical development enterprise applications to the cloud. This is the largest initiative of its kind for OmniComm since the launch of OmniCloud in June of this year.
Leading In Vitro Diagnostics Company Selects OmniComm's(R) TrialMaster(R) Electronic Data Capture Solution
Marketwire - Wed Sep 17, 7:35AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM), a global leading provider of clinical data management technology, is pleased to announce that a leading in vitro diagnostics (IVD) company has selected TrialMaster electronic data capture (EDC) to support its clinical evaluation of innovative IVD products for rapid identification and antibiotic susceptibility testing of infectious pathogens.
